Regulatory Affairs and Intellectual Property Rights in the Indian Pharmaceutical Industry at Chandigarh College of Pharmacy, Landran, Mohali, Punjab
Date of seminar : November 8, 2019 to November 9, 2019
Venue : Chandigarh College of Pharmacy, Landran, Mohali, Punjab
Organizer : Chandigarh College of Pharmacy, CGC, Landran, Mohali, Punjab
Organizing secretary : Dr. M. Arockia Babu, Director-Principal, Chandigarh College of Pharmacy, Landran
Email Id of conference : conferenceccp@gmail.com
Abstract submission last date : November 5, 2019
For more information : Click Here
For Broucher Link : Click Here
Description :
In the era of modernization with digitalization and global knowledge sharing, the protection of intangible assets has become even more essential than ever before. Intellectual property rights (IPR) endows a secure environment for the investigators, scientists, traders etc. to encourage innovation and scientific expansion. IPR is a requisite for pharmaceutical companies for identification, planning, commercialization and protection of invention. The Patent Act, 1970 has played a significant role in taking India to the global patent arena. In this sector, while patents are the most visible and perhaps most important form of intellectual property, other IP instruments also play a significant role. In the product market, these include copyrights in supporting publications and materials, trademark protection of brands, and administrative mechanisms or sui generis provisions giving proprietary rights in clinical and manufacturing data used to support regulatory approval. In the R&D domain, contract law governing license agreements, collaborative ventures, disclosure of proprietary information, as well as statutes covering the rights of inventors vs. employers and the transfer of technology by publicly funded institutions, are critical to the operation of the “market for technology. Regulatory affairs in the pharma industry plays a critical role not only as the interface with health agencies and as a link between different departments in the company but also as the leading department to provide strategic advice on extremely difficult decisions through the life of a drug. This conference will enhance the knowledge of the budding pharmaceutical professionals towards the recent trends in IPR and DRA departments in Indian Pharmaceutical Industries.
Conference Speakers:
1. Mr. Girish Chavan
General Manager (Regulatory Affairs)
Lupin Limited
Mumbai
2. Dr. Venkatesh Katgeri
Head of Regulatory
Glenmark Life Sciences
Thane
3. Dr. Richa Prakash Khurana,
Group Leader (R&D, IP)
Ester Industries
New Delhi
4. Dr. Pramod Sagar
Deputy General Manager
Intellectual Property
Glenmark Pharmaceutical Ltd, Mumbai
5. Ms. Meenakshi Jain,
General Manager, Regulatory Affairs,
Mankind Pharma Pvt Ltd,
Gurgaon.
6. Dr. Shirshendu Das Gupta
Associate Director
Dr. Reddy’s Laboratories, Hyderabad
7. Mr. Sheetiz Chopra
Head-Regulatory Affairs
Centrient Pharmaceuticals
Toansa, SBS Nagar, Punjab
8. Ms. Rajni Jha
Pharmaceutical Consultant, Trainer for Qbd, GMP and Regulatory Affairs, New Delhi
9. Dr. Anand Sharma
Professor
NIPER, Mohali
10. Mr. Prashant M. Katariya
Senior Manager, Zydus Cadila
Ahmedabad
